Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohisa Baba

Showing results (171-180 of 249) with videos related to

Pageof 25
Sort By:
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 3, 2008
[Clinical features of pulmonary disease caused by Mycobacterium fortuitum]Eri Hagiwara, Akimasa Sekine, Tomohide Sato, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 17, 2008
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease]Eri Hagiwara, Akimasa Sekine, Tomohide Sato, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[A case of lung adenocarcinoma with gradual enlargement of thin-walled cavity causing pneumothorax]Akimasa Sekine, Eri Hagiwara, Takashi Ogura, et al.
Respiratory Investigation|April 14, 2024
Drug-related pneumonitis caused by amikacin liposome inhalation suspension: One pathologically proven case and single-center experienceTaichi Kaneko, Ryota Otoshi, Akimasa Sekine, et al.
BMC Pulmonary Medicine|February 1, 2018
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?Hideaki Yamakawa, Tamiko Takemura, Tae Iwasawa, et al.
Respiratory Investigation|February 23, 2021
Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung diseaseTakuma Katano, Akimasa Sekine, Satoshi Ikeda, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven CaseRyota Otoshi, Akimasa Sekine, Eri Hagiwara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
MHC class I-like MILL molecules are beta2-microglobulin-associated, GPI-anchored glycoproteins that do not require TAP for cell surface expressionMizuho Kajikawa, Tomohisa Baba, Utano Tomaru, et al.
Respiratory Research|June 26, 2026
Integrated phenotyping identifies reproducible prognostic subgroups in idiopathic pleuroparenchymal fibroelastosisRyota Otoshi, Hideya Kitamura, Tsuneyuki Oda, et al.
The Annals of Thoracic Surgery|June 28, 2015
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial PneumoniaTakahiro Omori, Michihiko Tajiri, Tomohisa Baba, et al.
Pageof 25

Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 3, 2008
[Clinical features of pulmonary disease caused by Mycobacterium fortuitum]Eri Hagiwara, Akimasa Sekine, Tomohide Sato, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 17, 2008
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease]Eri Hagiwara, Akimasa Sekine, Tomohide Sato, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[A case of lung adenocarcinoma with gradual enlargement of thin-walled cavity causing pneumothorax]Akimasa Sekine, Eri Hagiwara, Takashi Ogura, et al.
Respiratory Investigation|April 14, 2024
Drug-related pneumonitis caused by amikacin liposome inhalation suspension: One pathologically proven case and single-center experienceTaichi Kaneko, Ryota Otoshi, Akimasa Sekine, et al.
BMC Pulmonary Medicine|February 1, 2018
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?Hideaki Yamakawa, Tamiko Takemura, Tae Iwasawa, et al.
Respiratory Investigation|February 23, 2021
Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung diseaseTakuma Katano, Akimasa Sekine, Satoshi Ikeda, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven CaseRyota Otoshi, Akimasa Sekine, Eri Hagiwara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
MHC class I-like MILL molecules are beta2-microglobulin-associated, GPI-anchored glycoproteins that do not require TAP for cell surface expressionMizuho Kajikawa, Tomohisa Baba, Utano Tomaru, et al.
Respiratory Research|June 26, 2026
Integrated phenotyping identifies reproducible prognostic subgroups in idiopathic pleuroparenchymal fibroelastosisRyota Otoshi, Hideya Kitamura, Tsuneyuki Oda, et al.
The Annals of Thoracic Surgery|June 28, 2015
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial PneumoniaTakahiro Omori, Michihiko Tajiri, Tomohisa Baba, et al.
Pageof 25